[Importance of ANCAs in the pathogenesis of chronic inflammatory bowel diseases].
作者信息
Müller-Ladner U, Andus T, Lang B, Gross V
机构信息
Klinik und Poliklinik für Innere Medizin I, Universität Regensburg.
出版信息
Verh Dtsch Ges Pathol. 1996;80:215.
PMID:9065008
Abstract
摘要
相似文献
1
[Importance of ANCAs in the pathogenesis of chronic inflammatory bowel diseases].
Verh Dtsch Ges Pathol. 1996;80:215.
2
Autoimmune reactivity in inflammatory bowel disease.
Clin Lab Med. 1997 Sep;17(3):465-81.
3
Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Isr Med Assoc J. 2004 Apr;6(4):221-6.
4
Distinguishing between anti-neutrophil cytoplasmic antibody patterns in inflammatory bowel disease: is the "atypical pattern" adding more information?
Am J Gastroenterol. 2009 Jul;104(7):1854-5. doi: 10.1038/ajg.2009.144. Epub 2009 May 12.
5
Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
Tecnologica MAP Suppl. 1999 Jun:18-20.
6
Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
Clin Diagn Lab Immunol. 2005 Nov;12(11):1328-30. doi: 10.1128/CDLI.12.11.1328-1330.2005.
7
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Am J Gastroenterol. 2001 Mar;96(3):730-4. doi: 10.1111/j.1572-0241.2001.03613.x.
8
P-ANCA as a differential diagnostic marker in inflammatory bowel disease.
Adv Exp Med Biol. 1995;371B:1313-6.
9
Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases.
Z Gastroenterol. 1997 Jan;35(1):29-32.
10
The genetics and immunopathogenesis of inflammatory bowel disease.
Nat Rev Immunol. 2008 Jun;8(6):458-66. doi: 10.1038/nri2340.
Zotero 插件